Found 4 matching trials
Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia PHASE3 The primary objective is to evaluate the hypnotic efficacy of zolpidem-MR (...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIA PHASE4 Primary Objective:
To evaluate the efficacy and safety of the use of Stiln...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG) PHASE3 The primary objective of the study is to evaluate the hypnotic efficacy of ...
Show More Learn More & Join Trial
Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia PHASE3 There has been an increased interest in the association between ADHD and sl...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial